Individuals prescribed the antidiabetes treatment metformin less likely developed a myeloproliferative neoplasm —potentially also reducing a person’s chances for developing certain cancers — according to data published in Blood Advances.Metformin is a therapy used by patients with type 2 diabetes to treat high blood sugar by increasing the efficacy of insulin.